Craniopharyngioma is a type of benign brain tumor. It is called benign because the abnormal cells do not travel and grow in other parts of the body. Even though they don't spread to other parts of the body, they can cause problems by growing in the brain. They will press against the brain and cause issues.
This tumor results from an abnormal overgrowth of the part of the brain called Rathke's pouch. It is near the pituitary gland. The tumor is often partially a solid and partially fluid-filled cyst. It can contain calcium deposits and the fluid is made up of protein, lipid (fat), and cholesterol pieces. This growth can cause problems with hormone secretion and vision because of where it is in the brain.
Craniopharyngiomas occur in children and adults, most often in children ages 5-14 and adults ages 50-75. There are about 350 new cases diagnosed each year. The cause of these tumors is not known. Some researchers think that they begin to grow before birth, but it is not associated with any race, gender, or family history.
Craniopharyngioma cannot be prevented because the cause of the tumor is not known.
There are no screening tests for craniopharyngioma.
Symptoms of craniopharyngioma are caused by the pressure on the brain, nerves, and blood vessels from the growing tumor. Where in the brain the tumor presses determines the type of symptoms a child has. Often, there are changes to vision and a child's growth can be affected. Growth changes are related to changes in hormones from the tumor affecting the pituitary gland. In general, side effects can include:
Each child can have different symptoms. If your child is having any changes in their normal activity, growth, or is having any changes in health, they should be seen by their provider.
A number of tests can be used to help diagnose craniopharyngioma:
Staging is often used in cancer to help create a treatment plan. Staging takes into account how large a tumor is, how it looks under a microscope, and if it has spread. There is no standard staging system for craniopharyngioma because it rarely spreads to other parts of the body. Some providers will describe it as newly diagnosed or recurrent.
It is important to find a pediatric facility that has experience treating patients with craniopharyngioma. A team of specialists, along with you and your child, will determine the best treatment plan. A major factor when determining the treatment plan is whether the whole tumor can be removed with surgery. Something to consider when planning a treatment course is that there is potential for late or long-term side effects, meaning side effects that can occur after treatment has ended. Late effects of treatment for craniopharyngioma can include issues with vision, hormone imbalances, neurological issues, and issues with growth and weight gain. The provider should speak about these possible side effects.
Surgery is the most common treatment used. The goal is to surgically remove the whole tumor but this is not always possible. If the tumor has grown into a major blood vessel or the optic nerve, or if the surgery itself could damage the brain and the child's functioning, then other treatments may be used. Other treatments may also be used if only part of the tumor is removed. The types of surgery used include:
The type of surgery used will depend on how big the tumor is and where it is in the brain. Your child's providers will talk to you about if surgery is right for your child and the method used.
In some cases, radiation is done after surgery, especially if only part of the tumor was removed. Radiation is the use of high energy x-rays to kill cancer cells. Radiation can be used instead of surgery, after surgery, or if the tumor comes back. There is both internal and external radiation:
The type of radiation used will depend on each individual situation.
Chemotherapy is the use of medications that kill cancer cells. It can be given into a vein (IV), into a muscle, by mouth, into the cerebrospinal fluid, or into the tumor itself. Chemotherapy is often used to treat tumors that are not in the brain or in cases where the cancer has spread to different parts of the body. Intracavitary chemotherapy, or chemo injected directly into the tumor, can be used for a recurrent craniopharyngioma.
Immunotherapy is the use of medications that use the patient's own immune system to fight the cancer. Interferon-alfa is a type of immunotherapy and it can be injected into the cyst. This can be used to delay other treatment or in a tumor recurrence.
There are clinical research trials for most types of cancer, and every stage of the disease. Clinical trials are designed to determine the value of specific treatments. Trials are often designed to treat a certain stage of cancer, either as the first form of treatment offered, or as an option for treatment after other treatments have failed to work. They can be used to evaluate medications or treatments to prevent cancer, detect it earlier, or help manage side effects. Clinical trials are extremely important in furthering our knowledge of the disease. It is through clinical trials that we know what we do today, and many exciting new therapies are currently being tested. Talk to your provider about participating in clinical trials in your area. You can also explore currently open clinical trials using the OncoLink Clinical Trials Matching Service.
After treatment for childhood cancer, you will be followed closely to monitor for the cancer coming back, to manage ongoing side effects, and to transition to survivorship. At first you will have frequent appointments with providers and have ongoing tests to monitor your health. As time goes on, these visits and testing will become less frequent. The oncology team will discuss the plan for follow up.
What can you do to live a healthy life after treatment? There is no supplement or specific food you can eat to assure good health, but there are things you can do to live healthier, prevent other diseases, detect cancers early and work with the social and emotional issues, including insurance, employment, relationships, sexual functioning, and fertility, that a prior cancer diagnosis sometimes brings with it. Your oncology team is there to support you and can help you find support resources.
It is important to have a plan for who will provide follow up care (an oncologist, survivorship doctor or primary care doctor). Talk with the team about developing a survivorship care plan or develop one using the Smart ALACC tool. Your child may benefit from being seen in a survivorship clinic. At a survivorship clinic a provider can review your child's history and provide recommendations. You can contact cancer centers in your area to see if they have a survivor's clinic or search for a clinic on OncoLink's survivorship clinic list.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania